Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Laura on +44 (0) 1494 818026 or laura@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Laura Marsh
Recruitment Consultant
laura@zenopa.com
+44 (0) 1494 818026

Testimonials
I have say that Zenopa were extremely professional and were a thorough consultancy to work with and I was always impressed with their attention to detail.
Mark, 2013

Pfizer to safeguard jobs at Kent research facility

24 June 2011 00:00 in Pharmaceutical Company Restructures


Pfizer has indicated that about 350 jobs will be preserved at its research and development centre in Sandwich.

The company announced plans to phase out the Kent facility earlier this year, but has now revealed its intention to retain a partial pharmaceutical sciences operation on the site.

Pfizer will continue with its plan to vacate the remainder of the centre, which has been renamed Discovery Park in a bid to attract new occupants, by the end of 2012.

Meanwhile, the firm's Dr Annette Doherty is due to take over from Dr Ruth McKernan as site director.

In a statement, the pharmaceutical giant said its decision to retain a presence in Sandwich was made following a "rigorous diligence process".

A company spokesperson explained: "Pfizer determined that retaining a portion of its pharmaceutical sciences operation at Sandwich presents the best solution at this time for Pfizer's business."

The firm's announcement was welcomed by Kent County Council and David Willetts, minister of state for universities and science.ADNFCR-8000103-ID-800598610-ADNFCR

Other news stories from 24/06/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd